title: Etanercept and the treatment of multicentric reticulohistiocytosis.
authors.forename: Kelli
authors.initials: K
authors.lastname: Lovelace
authors.forename: Aaron
authors.initials: A
authors.lastname: Loyd
authors.forename: David
authors.initials: D
authors.lastname: Adelson
authors.forename: Neil
authors.initials: N
authors.lastname: Crowson
authors.forename: J R
authors.initials: JR
authors.lastname: Taylor
authors.forename: Raymond
authors.initials: R
authors.lastname: Cornelison
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D000068800:Etanercept; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D017211:Treatment Failure
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept